Massimiliano Gnecchi

8PUBLICATIONS
58CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapyCentral nervous systemCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 22, 2026
Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation.

|May 13, 2026
MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome.

|Jun 28, 2024
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.

Lia Crotti, Raquel Neves, Federica Dagradi

|Jul 28, 2022
From novel discovery tools and biomarkers to precision medicine-basic cardiovascular science highlights of 2021/22.

Paul C Evans, Sean M Davidson, Johann Wojta

|Jul 25, 2022
Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases.

Mariann Gyöngyösi, Pilar Alcaide, Folkert W Asselbergs

|Jul 23, 2021
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study.

Sara Paris, Riccardo M Inciardi, Carlo Mario Lombardi

Pageof 2

Frequent Collaborators

4 joint publications

Luca Sala

4 joint publications

Peter J Schwartz

3 joint publications

Giulia Musu

3 joint publications

Fulvio L F Giovenzana